Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

Details 詳細情報について

• CRID

  1363388846009574144

• DOI

  10.1016/s1474-4422(11)70108-9

• ISSN

  14744422

• Web Site

  https://api.elsevier.com/content/article/PII:S1474442211701089?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1474442211701089?httpAccept=text/plain

• Data Source

  • Crossref